Skip to article content

The Harvey L. Neiman Health Policy Institute® studies the value and role of radiology in evolving health care delivery and payment systems, including quality based approaches to care and the impact of medical imaging on overall health care costs. Neiman Institute research provides a foundation for evidence-based imaging policy to improve patient care and bolster efficient, effective use of health care resources. Read the 2016 Neiman Institute Annual Report.

New Study Reveals 75% of Multiple Sclerosis Patients Face Financial Toxicity

A new study from Harvey L. Neiman Health Policy Institute finds that over ¾ of Multiple Sclerosis (MS) patients face financial toxicity that often results in non-adherence to follow up care. This study is the first of its kind to evaluate financial toxicity in MS and whether financial strain is linked to patients foregoing the therapy and imaging follow-up prescribed in their treatment plan. Read More

About the Harvey L. Neiman Health Policy Institute

The Harvey L. Neiman Health Policy Institute® studies the value and role of radiology in evolving health care delivery and payment systems, including quality based approaches to care and the impact of medical imaging on overall health care costs. Neiman Institute research provides a foundation for evidence-based imaging policy to improve patient care and bolster efficient, effective use of health care resources. Read the 2016 Neiman Institute Annual Report.

Read More

Video

Latest Updates

National Trends in Oncologic Diagnostic Imaging

This study characterize national trends in oncologic imaging (OI) utilization. This retrospective cross-sectional study used 2004 and 2016 CMS 5% Carrier Claims Research Identifiable Files. Radiologist-performed, primary noninvasive diagnostic imaging examinations were identified from billed Current Procedural Terminology codes; CT, MRI, and PET/CT examinations were categorized as “advanced” imaging. OI examinations were identified from imaging claims’ primary International Classification of Diseases-9 and International Classification of Diseases-10 codes. Imaging services were stratified by academic practice status and place of service. State-level correlations of oncologic advanced imaging utilization (examinations per 1,000 beneficiaries) with cancer prevalence and radiologist supply were assessed by Spearman correlation coefficient.OI usage varied between practice settings. Although the percentage of advanced OI done in academic settings nearly doubled from 2004 to 2016, the majority remained in nonacademic practices. Full Article

Andrew B. Rosenkrantz, MD, Laura Chaves Cerdas, MS, Danny R. Hughes, PhD, Michael P. Recht, MD, Sharyl J. Nass, PhD, Hedvig Hricak, MD, PhD. 2020. "National Trends in Oncologic Diagnostic Imaging," Journal of American College of Radiology (JACR): 1116 - 1122.

Patient-reported financial toxicity in multiple sclerosis: Predictors and association with care non-adherence

Multiple sclerosis (MS) results in considerable financial burdens due to expensive treatment and high rates of disability, which could both impact care non-adherence. Full Article

Gelareh Sadigh, Ruth Carlos, Carolyn Meltzer, Jeffrey M. Switchenko, Neil Lava, Rich Duszak, Danny Hughes, Elizabeth Anne Krupinski. 2020. "Patient-reported financial toxicity in multiple sclerosis: Predictors and association with care non-adherence," Multiple Sclerosis

September 8, 2020

New Study Reveals 75% of Multiple Sclerosis Patients Face Financial Toxicity

A new study from Harvey L. Neiman Health Policy Institute finds that over ¾ of Multiple Sclerosis (MS) patients face financial toxicity that often results in non-adherence to follow up care. This study is the first of its kind to evaluate financial toxicity in MS and whether financial strain is linked to patients foregoing the therapy and imaging follow-up prescribed in their treatment plan. Read More